Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
96,549,099
-
Share change
-
+94,511,659
-
Total reported value
-
$1,598,552,000
-
Price per share
-
$16.58
-
Number of holders
-
55
-
Value change
-
+$1,564,771,001
-
Number of buys
-
53
Institutional Holders of CEREVEL THERAPEUTICS HLDNG I - COM (CERE) as of Q4 2020
As of 31 Dec 2020,
CEREVEL THERAPEUTICS HLDNG I - COM (CERE) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
96,549,099 shares.
The largest 10 holders included
Bain Capital Investors LLC, PERCEPTIVE ADVISORS LLC, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, Artal Group S.A., RA CAPITAL MANAGEMENT, L.P., Ally Bridge Group (NY) LLC, ALKEON CAPITAL MANAGEMENT LLC, and CITADEL ADVISORS LLC.
This page lists
55
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.